Strategies: China Cardiovascular Drugs Industry 2014 , Global Industry Analysis, Size, Share, Growth, Trends and Forecast

Submitted by: Submitted by

Views: 59

Words: 597

Pages: 3

Category: Business and Industry

Date Submitted: 06/17/2014 03:11 AM

Report This Essay

Research on China Cardiovascular Drugs Industry, 2014-2018 primarily carries on analyses on cardiovascular drugs market in the following aspects: market scale, the scale of segment markets, current competition status and business performance of major drug manufacturers; meanwhile it makes predictions about prospective market so as to help investors know this industry well and provide decision-making references for them.

With the aged tendency of population in China and the increasing morbidity of chronic diseases which have to be treated with medicines for the rest of patients life, market scale of cardiovascular drugs is expanding. This trend has been reflected in recent years. While in the next few years, with the reform of medical insurance in China and the continuous standardization of pharmaceutical market as well as the unique curative effect of Chinese patent medicines, Chinese patents medicines for cardiovascular diseases will enjoy a promising development prospect.

In 2013 market scale of cardiovascular drugs has reached CNY 17.8 billion in China. At present cardiovascular diseases have a relatively higher morbidity rate among all diseases and also is a kind of disease that is hard to be cured. Along with the changes of peoples life-styles, the difficulties in curing cardiovascular diseases are becoming more prominent. The compound annual growth rate of cardiovascular diseases is 21.6%, and the prevalence rate of cardiovascular diseases will increase further because of the improvements on peoples living standards, the changes of life styles and increasing aging population. The market will be expanded.

On the other hand, patients with cardiovascular diseases have stood at 290 million, and patients with chronic diseases who have received systematic treatment account for a small proportion. In the next ten years, there is a potential for the growth in cardiovascular diseases treatment field. It is predicted that the growth rate will maintain more...